MetaCap

Standard BioTools (LAB) vs Rapid Micro Biosystems (RPID)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Standard BioTools (LAB) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 54.3% versus a loss of 82.4%. Over five years, LAB leads with a -86.5% price change compared with -94.4% for RPID. Standard BioTools is the larger company by market cap ($249.1 million vs $37.4 million), about 6.7 times the size, while Rapid Micro Biosystems is growing revenue faster (+19.7% vs -6.2%).

Standard BioTools converts more of its revenue into profit, with a net margin of -87.8% versus -140.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LAB-54.28%RPID-82.37%
+27%-32%-90%
Nov 21, 20251 yearNov 20, 2026
LAB-85.95%RPID-95.40%
+9%-46%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LAB versus RPID key metrics
MetricLABRPID
Share price$0.631$0.735
Market cap$249.11M$37.37M
1-day change+2.82%-0.04%
YTD return-50.70%-74.66%
1-year return-54.28%-82.37%
5-year return-86.55%-94.41%
EPS (TTM)$-0.09$-1.06
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$85.33M$33.59M
Revenue growth (YoY)-6.24%+19.74%
Net income (latest FY)$-74.90M$-47.12M
Gross margin49.86%—
Operating margin-129.20%-141.10%
Net margin-87.77%-140.30%
52-week high$1.72$4.94
52-week low$0.39$0.58
Distance from 52-week high-63.31%-85.12%
Analyst consensusnonestrong_buy
Avg. price target upside+113.95%+682.31%
Average volume1.16M577.05K
Shares outstanding394.79M46.34M
Employees385171
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Standard BioTools is about 6.7 times larger than Rapid Micro Biosystems by market value ($249.11M vs $37.37M).
  • LAB has outperformed RPID by 28.1 percentage points over the past year.
  • Standard BioTools is more profitable, keeping -87.8 cents of every revenue dollar as net income versus -140.3 cents for Rapid Micro Biosystems.
  • Rapid Micro Biosystems grew revenue faster in its latest fiscal year (+19.74% vs -6.24%).

About Standard BioTools

LAB stock →

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.

Industrials · Biotechnology: Laboratory Analytical Instruments · 385 employees

About Rapid Micro Biosystems

RPID stock →

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees

LAB vs RPID FAQ

Which is bigger, Standard BioTools or Rapid Micro Biosystems?

Standard BioTools (LAB) is larger, with a market capitalization of $249.11M compared with $37.37M for Rapid Micro Biosystems (RPID).

Which stock has performed better over the past year, LAB or RPID?

LAB returned -54.28% over the past 12 months, compared with -82.37% for RPID (price return, excluding dividends). Past performance does not predict future results.

Are Standard BioTools and Rapid Micro Biosystems in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons